LRH-1/NR5A2 Antibody (PCRP-NR5A2-1B8) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26934G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry-Paraffin
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # PCRP-NR5A2-1B8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human LRH-1/NR5A2 protein
Localization
Nucleus
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for LRH-1/NR5A2 Antibody (PCRP-NR5A2-1B8) [DyLight 488]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LRH-1/NR5A2
Long Name
Liver Receptor Homolog 1/Nuclear Receptor Subfamily 5, Group A, Member 2
Alternate Names
B1F2, FTZ-F1 beta, LRH1, NR5A2
Gene Symbol
NR5A2
Additional LRH-1/NR5A2 Products
Product Documents for LRH-1/NR5A2 Antibody (PCRP-NR5A2-1B8) [DyLight 488]
Product Specific Notices for LRH-1/NR5A2 Antibody (PCRP-NR5A2-1B8) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...